Immediate Impact
57 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
2024 Standout
Works of Xinqun Yang being referenced
Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer
2010
An Open-Label Clinical Trial Evaluating Safety and Pharmacokinetics of Two Dosing Schedules of Panitumumab in Patients with Solid Tumors
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xinqun Yang | 253 | 113 | 47 | 170 | 7 | 399 | |
| Stephen Eppler | 183 | 37 | 46 | 140 | 9 | 392 | |
| Maksim Yezhelyev | 242 | 49 | 55 | 172 | 6 | 417 | |
| Colvin Om | 170 | 190 | 52 | 83 | 11 | 425 | |
| Steven King | 285 | 54 | 29 | 114 | 7 | 457 | |
| Giovanni Pacchiana | 259 | 34 | 37 | 96 | 7 | 357 | |
| Sanaa T. Dergham | 174 | 95 | 45 | 314 | 11 | 450 | |
| LA Falk | 273 | 111 | 21 | 97 | 8 | 421 | |
| G�nther Gastl | 207 | 36 | 94 | 111 | 8 | 432 | |
| LR Ellingsworth | 225 | 242 | 39 | 95 | 8 | 429 | |
| Francis Lopez | 152 | 94 | 30 | 123 | 11 | 392 |
All Works
Loading papers...